HDII (Hypertension Diagnostics) Other Stockholders Equity: $-0.00 Mil (As of Sep. 2019)


What is Hypertension Diagnostics Other Stockholders Equity?

Hypertension Diagnostics HDII -99.00% Other Stockholders Equity is $-0.00 Mil as of Sep. 2019.

Hypertension Diagnostics's Other Stockholders Equity for the quarter that ended in Sep. 2019 was $-0.00 Mil.

Hypertension Diagnostics's quarterly Other Stockholders Equity stayed the same from Mar. 2019 ($-0.00 Mil) to Jun. 2019 ($-0.00 Mil) and stayed the same from Jun. 2019 ($-0.00 Mil) to Sep. 2019 ($-0.00 Mil).

Hypertension Diagnostics's annual Other Stockholders Equity increased from Dec. 2016 ($-0.00 Mil) to Dec. 2017 ($-0.00 Mil) but then declined from Dec. 2017 ($-0.00 Mil) to Dec. 2018 ($-0.00 Mil).

Hypertension Diagnostics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Other Stockholders Equity Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 -0.00 -0.00 -0.00

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 -0.00 -0.00 -0.00

Hypertension Diagnostics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Hypertension Diagnostics (HDII) has a Other Stockholders Equity of $-0.00 Mil as of Sep. 2019. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' Other Stockholders Equity too high?
Hypertension Diagnostics' current Other Stockholders Equity is $-0.00 Mil.
How does Hypertension Diagnostics' Other Stockholders Equity compare to ESTRF and OCLN?
Hypertension Diagnostics' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Diversified Financial Services company?
A good Other Stockholders Equity depends on the Diversified Financial Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Hypertension Diagnostics and its competitors. Hypertension Diagnostics's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Other Stockholders Equity is $-0.00 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.